UPDATE: Japan's Sysmex Acquires Germany's Inostics, Partec | GenomeWeb

This story has been updated from a previous version to incorporate information about Sysmex's acquisition of Partec.

NEW YORK (GenomeWeb News) — Japanese in vitro diagnostics firm Sysmex said yesterday that it has acquired a pair of German companies in a bid to bolster its personalized medicine and companion diagnostics development business.

Specifically, Sysmex acquired Hamburg-based Inostics and its US subsidiary Inostics Inc., based in Baltimore, Md. Sysmex has also acquired Görlitz-based flow cytometry firm Partec.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.